HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meena S Moran Selected Research

Hormones (Hormone)

1/2022DCIS: Risk Assessment in the Molecular Era.
1/2021NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
1/2020Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
1/2019NCCN Guidelines Insights: Breast Cancer, Version 3.2018.
12/2017Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
12/2017Discussion of: "Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?"
1/2017NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
1/2014Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?
9/2013The relative benefits of tamoxifen in older women with T1 early-stage breast cancer treated with breast-conserving surgery and radiation therapy.
2/2013Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meena S Moran Research Topics

Disease

66Breast Neoplasms (Breast Cancer)
12/2023 - 03/2002
36Neoplasms (Cancer)
12/2023 - 07/2008
13Noninfiltrating Intraductal Carcinoma (DCIS)
01/2022 - 03/2011
7Neoplasm Metastasis (Metastasis)
01/2019 - 03/2002
4Ductal Carcinoma
04/2016 - 12/2009
3Triple Negative Breast Neoplasms
03/2015 - 05/2013
2Carcinoma (Carcinomatosis)
01/2018 - 12/2012
2Necrosis
08/2017 - 11/2012
1Unilateral Breast Neoplasms
12/2022
1COVID-19
06/2020
1Dermatitis
01/2017
1Body Weight (Weight, Body)
12/2012
1Hyperplasia
12/2012
1Heart Diseases (Heart Disease)
09/2011
1Adenocarcinoma
12/2009
1Margins of Excision
11/2008

Drug/Important Bio-Agent (IBA)

12Hormones (Hormone)IBA
01/2022 - 07/2008
11Estrogen ReceptorsIBA
12/2023 - 06/2011
7Progesterone Receptors (Progesterone Receptor)IBA
12/2023 - 06/2011
6Proteins (Proteins, Gene)FDA Link
06/2014 - 05/2009
5ParaffinIBA
02/2012 - 03/2010
3Biomarkers (Surrogate Marker)IBA
01/2023 - 11/2011
3Estrogens (Estrogen)FDA Link
12/2019 - 07/2008
3human ERBB2 proteinIBA
10/2013 - 06/2011
2ErbB Receptors (EGF Receptor)IBA
12/2023 - 12/2022
2Indicators and Reagents (Reagents)IBA
06/2014 - 08/2012
2Carrier Proteins (Binding Protein)IBA
08/2012 - 06/2011
2Dihydrotachysterol (AT 10)IBA
06/2010 - 11/2008
1Messenger RNA (mRNA)IBA
01/2019
1Co-Repressor ProteinsIBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Protons (Proton)IBA
01/2018
1huaierIBA
05/2016
1InterleukinsIBA
04/2016
1Interleukin-6 (Interleukin 6)IBA
04/2016
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2014
1Calcium-Sensing ReceptorsIBA
06/2014
1Phenobarbital (Luminal)FDA Link
01/2014
1TamoxifenFDA LinkGeneric
09/2013
1InterferonsIBA
05/2013
1Tetrazolium SaltsIBA
02/2013
1Fulvestrant (Faslodex)FDA Link
02/2013
1NF-kappa B (NF-kB)IBA
12/2012
1CardiotoxinsIBA
12/2012
1TESIBA
12/2012
1AZD 6244IBA
01/2012
1Angiogenesis InhibitorsIBA
12/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2011
1Snail Family Transcription FactorsIBA
06/2011
1EnzymesIBA
03/2010
1PlatinumIBA
03/2010
1ProgesteroneFDA LinkGeneric
11/2008
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2008
1Aromatase (CYP19)IBA
07/2008
1Dinoprostone (PGE2)FDA Link
07/2008

Therapy/Procedure

40Radiotherapy
12/2023 - 03/2002
35Segmental Mastectomy (Lumpectomy)
12/2023 - 07/2008
24Therapeutics
12/2023 - 03/2002
11Mastectomy (Mammectomy)
07/2021 - 03/2002
7Drug Therapy (Chemotherapy)
01/2019 - 11/2008
4Adjuvant Radiotherapy
12/2023 - 06/2010
4Neoadjuvant Therapy
04/2016 - 10/2009
1Ambulatory Care (Outpatient Care)
06/2020
1Treatment Delay
02/2019
1Proton Therapy
01/2018
1Adjuvant Chemotherapy
12/2017
1Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2016
1Complementary Therapies (Alternative Medicine)
01/2013